Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1993 | 03-1993 | 12-1992 | 03-1992 | 12-1991 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | 586,921 | N/A | 708,759 |
| Marketable Securities | N/A | N/A | 3,322,898 | N/A | 3,657,607 |
| Receivables | N/A | N/A | 2,172,875 | N/A | 1,870,733 |
| Inventories | N/A | N/A | 1,671,442 | N/A | 1,394,334 |
| Other current assets | 0 | 0 | 927,920 | 0 | 841,731 |
| TOTAL | $N/A | $N/A | $8,682,056 | $N/A | $8,473,164 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 6,515,817 |
| Investments And Advances | 0 | 0 | 158,806 | 0 | 106,550 |
| Other Non-Current Assets | 0 | 0 | 159,124 | 0 | 150,200 |
| TOTAL | $N/A | $N/A | $317,930 | $N/A | $6,772,567 |
| Total Assets | $N/A | $N/A | $16,820,510 | $N/A | $15,245,730 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 3,650 | N/A | 55,866 |
| Accounts payable and accrued liabilities | 0 | 0 | 994,175 | 0 | 741,344 |
| Other current liabilities | N/A | N/A | 1,317,905 | N/A | 1,303,123 |
| TOTAL | $N/A | $N/A | $3,432,856 | $N/A | $3,849,597 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 2,593,940 | N/A | 1,710,804 |
| aiOther Non-Current Liabilities | 0 | 0 | 210,092 | 0 | 200,923 |
| TOTAL | $N/A | $N/A | $2,804,032 | $N/A | $1,911,727 |
| Total Liabilities | $N/A | $N/A | $6,236,888 | $N/A | $5,760,791 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 750,292 | N/A | 747,462 |
| Retained earnings | N/A | N/A | 7,183,715 | N/A | 6,116,919 |
| Other shareholders' equity | 0 | 0 | 110,121 | 0 | 95,174 |
| TOTAL | $N/A | $N/A | $10,583,630 | $N/A | $9,484,402 |
| Total Liabilities And Equity | $0 | $0 | $16,820,518 | $0 | $15,245,193 |